Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001567619-18-002256
Filing Date
2018-09-07
Accepted
2018-09-07 14:00:59
Documents
1
Period of Report
2018-09-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 3084
  Complete submission text file 0001567619-18-002256.txt   4368
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Issuer) CIK: 0001048477 (see all company filings)

EIN.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 6 STONEGATE RD PONTOLA VALLEY CA 94028
Business Address
HERON ELAINE J (Reporting) CIK: 0001235471 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26727 | Film No.: 181059674